National joint procurement: cancel the qualification of Jiangxi Jingrui Pharmaceutical Co., Ltd.'s Sodium Bicarbonate Ringer's Injection and include the company in the list of violations.

The National Drug Procurement Office announced on August 15th that the Sodium Bicarbonate Ringer's Injection held by Jiangxi Jingrui Pharmaceutical Co., Ltd. has been selected as one of the drugs in the tenth batch of national centralized drug procurement. According to a notice released by the Jiangxi Province Drug Administration on August 15, 2025, the marketing authorization holder, Jiangxi Jingrui Pharmaceutical Co., Ltd., has deficiencies in confirmation and validation. To prevent risks, the drug administration has taken measures to suspend the production and sales of Sodium Bicarbonate Ringer's Injection by Jiangxi Jingrui Pharmaceutical Co., Ltd. The procurement office has decided to cancel the qualification of Jiangxi Jingrui Pharmaceutical Co., Ltd.'s Sodium Bicarbonate Ringer's Injection, and include the company in the "violation list", suspending its application qualification for participating in national centralized drug procurement activities from August 15, 2025 to February 14, 2027.